Summary
The effects of pretransplant herpes virus serology on the occurrence of grades II–IV acute graft-versus-host disease (GVHD) were studied in 262 recipients and their HLA-identical family donors. In 131 recipients on standard GVHD prophylaxis (either methotrexate or cyclosporin A) significant effects were observed for donor HSV serology (seropositivity associated with increased risk for GVHD) and donor EBV serology (seronegativity associated with increased risk). However, these effects were nonsignificant in the other 131 recipients on intensified GVHD prophylaxis (i.e., methotrexate combined with cyclosporin A, in vivo anti-T-cell monoclonal antibodies, or various procedures to reduce the T-cell numbers in the transplants).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bekkum DW Van, Roodenburg J, Heidt PJ, Van der Waaij D (1976) Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. JNCI 52: 401–404
Boström L, Ringdén O, Sundberg B, Linde A, Tollemar J, Nilsson B (1988) Pretransplant herpes virus serology and acute graft-versus-host disease. Transplantation 46: 548–552
Boström L, Ringdén O, Gratama JW, Jacobsen N, Prentice HG, Zwaan FE, Nilsson B, for the Leukemia Working Party of the European Group for Bone Marrow Transplantation (1990) A role of herpes virus load for the development of acute graft-versus-host disease. Bone Marrow Transplant 5: 321–326
Boström L, Ringdén O, Forsgren M (1991) Strong donor leukocyte reactivity for herpes simplex virus (HSV) antigen in HSV-immune donors, combined with recipient seropositivity for HSV, is associated with acute graft-versus-host disease. Scand J Immunol (in press)
Gale RP, Bortin MM, Van Bekkum DW, et al. (1987) Risk factors for acute graft-versus-host disease. Br J Haematol 67: 397–406
Gast GC De, Gratama JW, Ringdén O, Gluckman E (1987) The multifactorial etiology of graft-versus-host disease. Immunol Today 8: 209–212
Gratama JW, Zwaan FE, Stijnen T, et al. (1987) Herpes virus immunity and acute graft-versus-host disease. Lancet 1: 471–474
Gratama JW, Lennette ET, Lönnqvist B, et al. (1992) Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J Med Virol (in press)
Svedmyr EI, Ernberg J, Seeley O et al. (1984) Virologic, immunologic and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30: 437–450
Verdonck LF, Gast GC De, Van Heugten HG, Dekker AW (1990) A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 75: 776–780
Vossen JM, Heidt PJ (1990) Gnotobiotic measures for the prevention of acute graft-versus-host disease. In: Burakoff, Deeg, Ferrara, Atkinson (eds) Graft-versus-host disease, chap 21. Marcel Dekker, New York
Yao QY, Rickinson AB, Gaston JSH, Epstein MA (1985) In vitro analysis of the Epstein-Barr virus: host balance in longterm renal allograft recipients. Int J Cancer 35: 43–49
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gratama, J.W., Nat, H.v.d., Weiland, H.T. et al. Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II–IV acute graft-versus-host disease. Ann Hematol 64 (Suppl 1), A137–A139 (1992). https://doi.org/10.1007/BF01715367
Issue Date:
DOI: https://doi.org/10.1007/BF01715367